News & Events

The monthly webinars will feature expert talks and panel discussions highlighting real-world implementation, ethical innovation, and new teaching methodologies. During this webinar, Dr. Melissa Pires-Alves (Technische Universität Berlin) will discuss Xeno-Free 3D Bioprinting. 

During this two-day symposium, speakers will discuss various topics around the 3Rs. Registration to the event is free of charge but mandatory. 

The preliminary program is already available. 

During this workshop, experts will present how human-based in vitro and in silico approaches are being developed to model and study the brain, deepen our understanding of neurological processes, and translate findings into therapeutic and safety applications.

Twelve NAM information initiatives – together under the name NAMii – have joined forces to organise an inspiring webinar series. Find out how you can use these knowledge bases, search engines, infrastructures, and other tools to improve the efficiency and effectiveness of your NAM-based research! During this session, 3Ranker and iNoVA Hub will be presented. 

This seminar will feature two presentations: 

• Bioprinting of Organ Models for Biomedical Research - Prof. Dr. Jens Kurreck
• Basic considerations on models, methods and the 3Rs - Prof. Dr. Stefan Hippenstiel

This seminar will feature two presentations: 

• Innovative Approaches to 3R in Education & Training: The Role of Video and Virtual Reality- Dr. Dr. Lisa Ernst
• Replacement methods when investigating the gastro-intestinal tract - Prof. Jörg Aschenbach

• Virtual conference topic sessions of several talks and a group discussion
• The virtual poster session will be accompanied by scheduled discussions per sub-session (poster shared folder, web meeting, and Slack).
• The deadline for speaker abstract submissions and poster submissions is 30 June 2025. 

This conference wishes to bring together again all the stakeholders in the field with the scope to discuss future projects and policy changes that need to be implemented to successfully phase out the reliance on animal testing within the vaccines testing control strategy, including the importance of vaccines’ supply chain sustainability and continuity and the benefits of this in supporting the role of vaccines in One Health.